Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

China mobile services growth to be led by 5G and data demand through 2030, forecasts GlobalData

China’s mobile services market is set for a steady but modest revenue growth through 2030, as rising mobile data service revenues offset continued decline in voice and messaging revenues, says GlobalData, a leading intelligence and productivity platform. GlobalData’s China Mobile Communications Forecast (Q4 2025) reveals that the country’s mobile services revenue is expected to grow at […]
Read more

Insurance AI adoption tempered by systemic risks and structural vulnerabilities, reveals GlobalData

Artificial Intelligence (AI) adoption accelerates across the insurance ecosystem, yet underlying market realities temper widespread optimism. While intense competitive pressure forces insurers, brokers and reinsurers to fast-track AI-enabled tools, critical systemic risk concerns persist. Industry stakeholders increasingly flag structural vulnerabilities, warning that current models lack the requisite maturity for enterprise-wide deployment, reveals GlobalData, a leading […]
Read more

UK VC funding value crosses $10 billion during January-April 2026, reveals GlobalData

Venture capital (VC) funding activity in the UK accelerated sharply during January-April 2026, with total investment value doubling to $10.5 billion even as the number of deals edged down slightly by around 2% year-on-year (YoY), reveals the Financial Deals Database of GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: […]
Read more

Europe Treponema pallidum tests market to grow at 3% CAGR through 2036, forecasts GlobalData

Europe’s Treponema pallidum tests market is expected to witness steady growth, driven by the increasing burden of syphilis, growing concerns around delayed diagnosis, and expanding focus on sexually transmitted infections (STIs) surveillance and early disease detection. The resurgence of syphilis across multiple European countries is reinforcing the need for timely diagnostic interventions, supporting wider adoption […]
Read more

US strengthens global VC landscape dominance with 178% YoY jump in funding value during January-April 2026, reveals GlobalData

The US strengthened its dominance in global venture capital (VC) landscape during January-April 2026, riding on a stable deal-making momentum alongside a sharp surge in invested capital. While the total number of VC deals announced in the US edged up 1% year-on-year (YoY), the corresponding total VC funding value jumped by a massive 178%, according […]
Read more

ATS 2026: TETON-PPF study reinforces inhaled therapies potential in progressive pulmonary fibrosis, says GlobalData

Emerging Phase III evidence for inhaled treprostinil in progressive pulmonary fibrosis (PPF) is reinforcing industry expectations that combination therapy will shape the next phase of fibrotic lung disease treatment. TETON-PPF trial data presented at the 2026 American Thoracic Society (ATS) International Conference highlights the potential for inhaled therapies to complement existing antifibrotics, while intensifying competitive […]
Read more

ATS 2026: Jascayd reinforces combination therapy shift in US pulmonary fibrosis treatment, says GlobalData

New US subgroup data for Jascayd in idiopathic and progressive pulmonary fibrosis (IPF/PPF) is reinforcing the industry shift toward combination antifibrotic therapy in fibrotic lung disease management. Findings suggest the therapy can deliver meaningful clinical benefit alongside existing standard-of-care treatments, strengthening its commercial positioning as competitive intensity accelerates across the evolving pulmonary fibrosis treatment landscape, […]
Read more

India hip replacement market to grow at 10% CAGR through 2036, forecasts GlobalData

India’s hip replacement devices market is witnessing steady growth, driven by the rising prevalence of osteoarthritis, ageing population, and increasing adoption of advanced orthopaedic technologies to improve clinical outcomes. Against this backdrop, the primary hip replacement devices market in India is anticipated to grow at a compound annual growth rate (CAGR) of approximately 10% through […]
Read more

Every $10/barrel oil rise can cut up to 0.5pp off GDP growth in major oil-importing economies, says GlobalData

Escalating disruptions across key Middle East maritime corridors are tightening global energy supply and keeping a higher risk premium embedded in crude markets. Each sustained $10 per barrel increase in crude oil prices can shave roughly 0.1–0.5 percentage points (pp) off the annual GDP growth in major net energy-importing economies, consistent with a widely used […]
Read more

Japan endoscopy devices market to grow at 4% CAGR through 2036, forecasts GlobalData

Driven by the rising prevalence of gastrointestinal (GI) cancers and increasing demand for minimally invasive treatment options, the adoption of advanced endoscopic technologies continues to grow globally. Reflecting this trend, Japan’s endoscopy market is expected to witness steady expansion at 4% CAGR through 2036, supported by growing preference for minimally invasive interventions and steady technological […]
Read more

Private markets reshape wealth management as alternatives drive portfolio diversification and revenue growth,says GlobalData

Alternative investments are rapidly transforming global wealth management, as private markets move from niche offerings to core portfolio allocations. Wealth managers are expanding access to private equity, private credit, infrastructure, and real assets to meet rising demand for diversification, resilience, and long-term returns. This structural shift is also strengthening revenue models by reducing reliance on […]
Read more

US dominates high-value VC deal activity as investors prioritize mature startup ecosystems in Q1 2026, reveals GlobalData

High-value venture capital (VC) deals (≥$100 million) grew increasingly concentrated in just few markets during the first quarter (Q1) of 2026, with the US accounting for around 60% and nearly 88% of all the global deal volume and value, respectively. The widening funding gap highlights how investors are prioritizing mature startup ecosystems and scalable business […]
Read more

APAC banking giants face new reality as China slows and India rises, reveals GlobalData

Asia-Pacific’s (APAC) largest banks are entering a more fragmented era. The region’s financial heavyweights still dominate global rankings by revenue, but the latest numbers reveal a widening divergence between China’s state-backed lenders, Japan’s globally exposed megabanks, and India’s fast-expanding retail franchises, according to GlobalData, a leading intelligence and productivity platform. Murthy Grandhi, Company Profiles Analyst […]
Read more

First CAR-T therapy Satri-cel for solid tumors positions China at forefront of next oncology revolution, says GlobalData

Solid tumors are emerging as the next frontier for CAR-T innovation, with China poised to deliver the world’s first approved CAR-T therapy for gastric cancer. The anticipated approval signals a pivotal shift in oncology treatment, expanding CAR-T beyond hematological malignancies and intensifying competition in the rapidly evolving solid tumor landscape, where early clinical success, regulatory […]
Read more

Global banks navigate diverging fortunes as growth normalizes and risks reprice, says GlobalData

The fiscal year 2025 was one of the most divergent on record for global banking: at one extreme, state-owned Russian lenders capitalized on wartime interest rate regimes; at another, Chinese megabanks witnessed net interest margins compress under Beijing’s directive to support a slowing economy. Between these poles, US banks mostly held their ground while European […]
Read more
1 … 7 8 9 10 11 … 209